Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib

Background Selective inhibition of the BCR-ABL tyrosine kinase by RNA interference has been demonstrated in leukemic cells. We, therefore, evaluated specific BCR-ABL small interfering RNA silencing in BCR-ABL-positive cell lines, including those resistant to imatinib and particularly those with the...

Full description

Bibliographic Details
Main Authors: Michael Koldehoff, Lambros Kordelas, Dietrich W. Beelen, Ahmet H. Elmaagacli
Format: Article
Language:English
Published: Ferrata Storti Foundation 2010-03-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/5524